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doi:10.1016/j.jtcvs.2003.12.0091432 The Journal of Thoracic and CardObjective: We sought to determine the psychosocial and sexual concerns of patients
discharged from the hospital with implantable left ventricular assist devices.
Methods: Bridge-to-transplant patients with the Heartmate left ventricular assist
device received a psychosocial and sexual survey at 1 month after discharge from
the hospital. The survey consisted of 3 parts, with 5 questions in each category. The
patients were asked to complete the survey by circling the responses and to provide
more detailed answers when necessary.
Results: There were 8 male patients who completed the questionnaire. Psycholog-
ically, all patients expressed a positive mood and found support from family or
religious sources. The majority described a change in attitude and behavior. So-
cially, all patients described a change in lifestyle, as well as a change in the reaction
of family and friends. No patient went back to work or had the desire to return to
work until after transplantation. The minority of patients admitted to smoking or
drinking. Sexually, the majority had the desire or participated in sexual activities.
The majority of patients either used or were interested in using sexual stimulants.
There were no mechanical problems with the left ventricular assist devices.
Conclusions: Psychosocial and sexual conditions are altered in patients with heart
failure who are discharged with implantable left ventricular assist devices. At 1
month’s time interval, there is an improvement in mood, an adjustment in lifestyle,
and a positive shift in relations with family and friends. There is sexual desire, with
interest in sexual-enhancing medication. The most common concern is related to the
pump, such as the durability of the device or damage to the components.
The progress in circulatory assist technology has evolved to levels thatwere considered unimaginable a decade ago. Advances in the field ofventricular assist device (VAD) and total artificial heart engineeringhave allowed surgeons to consider mechanical support as a means ofpermanent therapy.1,2 The ability to discharge patients from thehospital with implantable left ventricular assist device (LVAD)
systems has become a standard practice, with the realization that long-term support
is subject to device-related and nondevice-related issues. Although considerable
attention has focused on mechanical concerns of the pumps,3 less information is
known about the personal adjustment of the patients.4 The purpose of this report is
to describe the psychosocial and sexual concerns of patients discharged with
implantable LVADs awaiting transplantation.
Patients and Methods
Between July 1999 and March 2003, 24 patients received Heartmate implantable LVADs
(Thoratec Laboratories, Inc, Pleasonton, Calif) as a bridge to transplantation. The decision for
LVAD implantation was failure of maximal medical therapy to maintain stable hemodynam-
ics or end-organ perfusion. After LVAD placement, the patients and their spouses or
significant others were trained for outpatient management by the VAD nurse practitioner.
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with weekly follow-up for 1 month, biweekly follow-up for the
second month, and monthly follow-up thereafter. Only those pa-
tients who were discharged to home were included in the study.
Only bridge-to-transplant patients were surveyed.
An outpatient psychosocial and sexual survey was conducted
after the first month after discharge to home. This questionnaire
consisted of 3 parts: psychologic, social, and sexual. Each of the 3
categories contained 5 questions that addressed mental and phys-
ical issues of the patients with respect to the presence of the pump
(Table 1). This report documents the responses to the questionnaire
(Table 2). The patients were asked to complete the survey with
their spouse or significant other. The survey allowed for patients to
qualify their answers (with an area to write in additional responses)
to clarify and gain a more thorough appreciation of the responses.
Results
Eight patients were discharged from the hospital. All were
men with a mean age of 50.5 years (range, 22-59 years) and
a median age of 54.5 years. Five of the 8 patients were
married with children, one was engaged to be married with
children, and 2 patients were engaged to be married without
children. All patients completed the survey. Four patients
were given a diagnosis of ischemic dilated cardiomyopathy,
3 were given a diagnosis of idiopathic dilated cardiomyop-
athy, and one was given a diagnosis of familial cardiomy-
opathy.
Psychologically, all patients expressed a positive mood
at the 1-month time interval. In addition, all patients found
family support, religious support, or both to be helpful in
their recovery. Half of the patients required psychologic
counseling with the need for medication to cope with anx-
iety, depression, or both. The most common concerns were
related to the LVADs and to their families. Specifically, the
LVAD issues clustered around function and durability:
Would the LVAD maintain support until heart transplanta-
tion was achieved? Family concerns were related to per-
sonal survival to be with family members, as well as family
welfare from emotional and financial aspects. Socially, all
patients reported a change in their lifestyle to accommodate
the LVAD. There were positive changes noted, such as
increased activity level, endurance, and overall energy lev-
els. There were alterations in daily living related to the
LVAD, such as driveline site maintenance, washing, battery
charging, and transportation limitations. The interactions
with family and friends were changed because of the
LVAD. A deeper concern and a closer relationship with
people were observed on all accounts. On occasion, a ce-
lebrity-type status was described by several individuals.
Although none of the patients worked, half expressed an
interest in returning to work after recovery from transplan-
tation. Three of the 8 patients admitted to drinking alcoholic
beverages or smoking: these activities were irregular and
infrequent.
The Journal of ThoracicSexually, 7 of the 8 patients were sexually interested (n
 2) or sexually active (n  5) within 1 month after
discharge. Although there were no problems encountered
with the LVAD during sexual activities, patients did express
concern about the device, particularly the driveline. Inter-
estingly, one patient was concerned about the ability to have
children, thinking the presence of the machine made him
sterile. The attitude toward sexual behavior was mixed, with
half the patients describing a change in a positive direction.
Correspondingly, the majority of patients were interested
(no. 3) in or actually used (no. 3) sexual stimulants. No
adverse events were reported in those patients who used
sildanafil or alprostadil.
Discussion
The psychosocial and sexual issues of patients with implant-
able LVADs are becoming a visible part of the overall care
of patients using these technologies. It is a stark realization
TABLE 1. Psychosocial and sexual survey (circle re-
sponse, write in additional thoughts)
Psychological
1. Has your emotional state changed since the LVAD? Yes,
No, Other
2. What are your top three concerns? Myself, The LVAD,
Other
3. Have you received psychological counseling or medication?
Yes, No
4. Has your attitude and behavior changed since receiving
the LVAD? Yes, No
5. Do you find religion and/or support groups/services to be
helpful? Yes, No, Other
Social
1. Have you had occasion to smoke, drink (alcohol), or
partake in recreational drug use? Smoke, Alcohol, Drugs,
Other
2. Do you socialize and interact more or less with friends and
family since the LVAD? More, Less, Same
3. Have you gone back to work or desire to do so? Yes, No,
Other
4. Has your lifestyle changed since the LVAD? Yes, No, Other
5. Are your family and friends reacting to your situation any
differently? Yes, No, Other
Sexual
1. Do you have the desire and/or have you engaged in sexual
activity? Yes, No, Other
2. What are your concerns about sexual activity on the
LVAD? Myself, The LVAD, My partner, Other
3. Have you experienced any problems with your performance
or the LVAD’s function during sexual activity? Yes, No,
Other
4. Have you had the need for any medications, such as
Viagra? Medication, No Medication, Other
5. Has your attitude about sex changed since the LVAD
surgery? Yes, No, Other
LVAD, Left ventricular assist device.that patients discharged with LVADs are engaging in activ-
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versations with VAD practitioners from numerous VAD
centers are filled with stories of outpatients involved with
functions that were inconceivable a decade ago. Patients are
playing sports, attending social events, and traveling world-
wide. The limits of activities are measured only by the
imagination. Indeed, the preparation and management of
patients with LVADs discharged from the hospital has
become a specialty of the VAD practitioner.5
Although the majority of our attention has focused on the
mechanical aspects of the technology and the medical con-
dition of the patient, a far less obvious need resides in the
emotional and mental well being of the LVAD recipient.
Despite the engineering aspects of the pump (ie, the dura-
bility and functionality of the system), the systemic effects
of artificial technology in the human species weighs heavily
on the psyche. The overall concern of patients with LVADs
was addressed in the question that asked what the biggest
concern was while receiving support. The answers clustered
around 2 responses: the durability of the pump and the
duration of pump dependence before a transplant. These
patients were clearly worried about the device breaking
down over time and the uncertainty of when a donor organ
would become available. An analogous scenario was ob-
served in patients with other implanted cardiac devices,
such as pacemakers and defibrillators. For some, the im-
planted device was readily accepted. For others, it was a
6
TABLE 2. Responses (abbreviated) to psychosocial and se
1 2 3
Age (y) 54 57 22
Psychologic
Positive mood Yes Yes Yes
Concerns VAD VAD VAD
Counseling No Yes No
Behavior change No Yes Yes
support Yes
(F)
Yes
(R/F)
Yes
(R/F)
Social
Substances No Smoke EtOH
Socialize Same Same More
Work No No No
Lifestyle change Yes Yes Yes
Family/friends change in
relations
Yes Yes Yes
Sexual
Active No Desire Yes
Concerns None Fatigue Child
Problems NA NA None
Medications No Viagra Viag
Attitude change No Yes Yes
VAD, Ventricular assist device; F, family; R, religion; EtOH, alcohol; LVAD, le
sildanafil; MUSE, alprostadil.symbol of loss, debilitation, independence, and resilience.
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specific psychosocial and sexual concerns, it is clear that the
majority of patients had an improvement in their condition
compared with baseline. Overall, patients felt better. The
LVAD, by virtue of its ability to improve cardiac output,
reversed many of the physical side effects of heart failure. In
so doing, the patients’ moods were uplifted, relations with
family and friends were restored or enhanced, and sexual
desires were fulfilled. Interestingly, these findings forced us
to reconsider the management of patients with heart failure
receiving mechanical assistance or replacement technolo-
gies. For example, based on early studies by Masters and
Johnson,7 a “cultural mythology” was adopted in which
sexual activity in patients with significant cardiovascular
disease was not recommended. Guidelines for the manage-
ment of sexual dysfunction in patients with cardiovascular
disease were adopted,8 with careful consideration toward
those patients with advanced degrees of heart failure (ie,
class III-IV). The use of sildanafil (Viagra), for example,
was contraindicated in patients with congestive heart fail-
ure. Implantation of an LVAD, however, automatically
changes the profile of patients with heart failure. Limitations
and restrictions in activities, sexual or otherwise, need to be
reconsidered. Adjustments in medications, such as -block-
ers, angiotensin-converting enzyme inhibitors, and nitrates,
need to be reassessed. The use of medications that were
otherwise considered contraindicated in heart failure need to
survey
Patient no.
4 5 6 7 8
50 57 59 50 55
Yes Yes Yes Yes Yes
VAD Family VAD Family VAD
Yes Yes No No Yes
Yes Yes No Yes Yes
Yes
(R/F)
Yes
(F)
Yes
(R/F)
Yes
(R/F)
Yes
(F)
No No No EtOH No
Same Same Same More Same
No No No No No
Yes Yes Yes Yes Yes
Yes Yes Yes Yes Yes
Yes Desire Yes Yes Yes
LVAD ED None LVAD LVAD
None ED None None None
MUSE Viagra Viagra Viagra No
Yes No Yes No No
tricular assist device; ED, erectile dysfunction; NA, Not applicable; Viagra,xual
ren
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patients supported with implantable LVADs. Although the
number of patients is small, there are several emerging
patterns. There are direct issues related to the technology,
and there are concerns related to the patient’s psychologic
homeostasis with himself and with others. Although this
patient population was small and limited to bridge-to-trans-
plant men, the results suggest that destination therapy pa-
tients of either sex might encounter similar findings. In this
regard the tracking and understanding of psychosocial and
sexual data needs to be refined. Although the questionnaire
used in this report gives practical insight regarding the
concerns of outpatients with implantable LVADs, the sur-
vey’s use as a standardized tool is limited. The Minnesota
Living with Heart Failure questionnaire, on the other hand,
is a well-established measure of the patients’ perceptions of
the effects of congestive heart failure on their lives.9 This
resource, in a modified form to address patients with
LVADs, might be of value. In short, this report serves as a
stimulus for future study.
Conclusions
Patients discharged with implantable LVADs have psycho-
social and sexual concerns that are related to the technology
and its effects on the mind and body. Overall, there is an
improvement in mood at 1 month’s time. There are changes
in lifestyle to accommodate the presence of the pump,
The Journal of Thoracicalterations in the relationships between friends and family,
and a desire toward intimacy. Recognition of these mental
and emotional states is critical to our global management of
patients with implantable LVADs. A standardized form
needs to be created to more completely analyze these sen-
sitive areas and others.
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